Article
Modulation of activated leukocyte cell adhesion molecule-mediated invasion triggers an innate immune gene response in melanoma.
The Journal of investigative dermatology - 1 May 2012
van Kilsdonk Jeroen W J, Takahashi Nozomi, Weidle Ulrich, Burtscher Helmut, Jarry Jonathan, Daha Mohamed R, Swart Guido W M, van Kempen Léon C L T
Abstract excerpt
Activated leukocyte cell adhesion molecule (ALCAM/CD166) is a progression marker of a variety of cancers, including melanoma, and is a marker for mesenchymal stem cells. ALCAM expression triggers matrix metalloproteinase activity and correlates with the transition between superficial melanoma growth and deep dermal invasion in vivo. We previously showed that manipulating ALCAM functionality could both decrease...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
